MOH — authorised 21 December 2012
- Marketing authorisation holder: AEGERION
- Status: likely_approved
🇮🇱 Juxtapid in Israel
MOH authorised Juxtapid on 21 December 2012
Marketing authorisation
Juxtapid in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in Israel
Frequently asked questions
Is Juxtapid approved in Israel?
Yes. MOH authorised it on 21 December 2012.
Who is the marketing authorisation holder for Juxtapid in Israel?
AEGERION holds the Israeli marketing authorisation.